Novelix Pharmaceuticals share news, announcements and annual reports
BSE: 536565Healthcare ServicesSmall Cap
NOVELIX PHARMACEUTICALS LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2013
Last close ₹66.01down ₹2.56 (3.73%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹68.57.
2 Nov: open ₹68.00, high ₹69.75, low ₹58.00
52-week range of traded prices to 2 Nov 2026
₹49.01Low, 7 Apr 2026₹92.00High, 16 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹188 Cr2,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 51.80
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 875
Novelix Pharmaceuticals board meetings
132 filed, newest first. Page 2 of 3.
Jun 2024
May 2024
16 May · Board meeting
Meeting on 28 May 2024: audited results
Mar 2024
Feb 2024
29 Feb · Board meeting
Meeting on 5 Mar 2024: preferential issue of shares
Jan 2024
23 Jan · Board meeting
Meeting on 30 Jan 2024: quarterly results
Dec 2023
15 Dec · Board meeting
8 Dec · Board meeting
Meeting on 15 Dec 2023: quarterly results
Oct 2023
12 Oct · Board meeting
Meeting on 17 Oct 2023: quarterly results
Aug 2023
10 Aug · Board meeting
3 Aug · Board meeting
Meeting on 9 Aug 2023: quarterly results
Apr 2023
20 Apr · Board meeting
Meeting on 29 Apr 2023: audited results
Feb 2023
1 Feb · Board meeting
Meeting on 9 Feb 2023: quarterly results
Dec 2022
5 Dec · Board meeting
Meeting on 5 Dec 20225 Dec · Board meeting
Nov 2022
1 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Aug 2022
2 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
Jul 2022
27 Jul · Board meeting
May 2022
16 May · Board meeting
Meeting on 28 May 2022: audited results
Jan 2022
31 Jan · Board meeting
Meeting on 12 Feb 2022: quarterly results27 Jan · Board meeting
19 Jan · Board meeting
Meeting on 27 Jan 2022
Nov 2021
2 Nov · Board meeting
Meeting on 12 Nov 2021: quarterly results
Sep 2021
Aug 2021
5 Aug · Board meeting
Meeting on 12 Aug 2021: quarterly results
Jun 2021
14 Jun · Board meeting
Meeting on 21 Jun 2021: audited results
Feb 2021
1 Feb · Board meeting
Meeting on 13 Feb 2021: quarterly results
Jan 2021
Oct 2020
27 Oct · Board meeting
Meeting on 6 Nov 2020: quarterly results
Aug 2020
14 Aug · Board meeting
Meeting on 20 Aug 2020: quarterly results
Jul 2020
Jun 2020
10 Jun · Board meeting
Meeting on 18 Jun 2020: audited results